维普中文期刊产品整合服务
360篇 您的检索式:作者名="Brekken"
    题名 作者 年代 出处 被引量
1PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer显示文摘Katherine T. Ostapoff Niranjan Awasthi Bercin Kutluk Cenik Stefan Hinz Keith Dredge Roderich E. Schwarz Rolf A. Brekken 2013Molecular Cancer Therapeutics2013,,7:2
2The VEGF family in cancer and antibody-based strategies for their inhibition显示文摘Laura A. Sullivan Rolf A. Brekken 2010mAbs2010,,:2
3Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis显示文摘Bergers G Brekken R McMahon G 0,,10:1
4A power analysis and data acquisition system for ocean wave energy device testing显示文摘AMON E BREKKEN TKA VON J A 2011Re- new Energy2011,36,:1
5Expression and characterization of murine hevin (SC1), a member of the SPARC family of matricellular proteins 显示文摘Brekken RA Sullivan MM Workman G 2004J Histochem Cytoehem2004,52,6:1
6Expression of soluble VEGF receptor 2 and characterization of its binding by surface plasmon resonance显示文摘 Gottstein C Brekken RA 1998Biochem Biophys Res Co mmun1998,252,3:1
7Secreted protein acidic and rich in cysteine as a regulator of murine ovarian cancer growth and chemosensitivity显示文摘Shawna L. Bull Phelps Juliet Carbon Andrew Miller Emely Castro-Rivera Shanna Arnold Rolf A. Brekken Jayanthi S. Lea 2009American Journal of Obstetrics and Gynecology2009,,2:1
8Vascular endothelial growth factor and vascular targeting of solid tumors显示文摘Brekken RA Thorpe PE 2001Anticancer Res2001,21,6:1
9Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM显示文摘BREKKEN R A PUOLAKKAINEN P GRAVES D C 2003J Clin Invest2003,111,4:1
10Optimal energy storage sizing and control for wind power applications 显示文摘BREKKEN YOKOCHI T K A VON JOUANNE A A 2011IEEE Transactions on Sustainable Energy2011,,:1
11Matrix metal- loproteinase-9 triggers the angiogenic switch during carci- nogenesis 显示文摘Bergers G Brekken R McMahon G 2000Nat Cell Biol2000,2,:1
12The angiogenic 'vascular endothelial growth factor/flk-1 (KDR)receptor'pathway in patients with endometrial carcinoma 显示文摘 Sivridis E Brekken R 2001Cancer2001,92,10:1
13Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogensis显示文摘Bergers G Brekken R McMahon G 2000Nature Cell Biol2000,2,:1
14Vascular Endothelial Growth Factor as a Marker of Tumor Endothelium 显示文摘Rolf A Brekken Huang XM 1998Cancer Res1998,58,:1
15Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients显示文摘Koukourakis MI Giatromanolaki A Brekken RA 2003Cancer Res2003,63,17:1
16Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis显示文摘BERGERS G BREKKEN R MCMAHON G 2000Nat Cell Biol2000,2,:1
17Control of a doubly fed induc- tion wind generator under unbalanced grid voltage conditions 显示文摘BREKKEN T K A MOHAN N 2007IEEE Trans on Energy Conversion2007,22,1:1
18Fibulin-5, an integrin-binding matricellular protein: its function in development and disease显示文摘Yanagisawa H Schlutennan M K Brekken R A 2009J Cell Commun Signal2009,3,34:1
19MMP and triggets the angiogenesis switch during carciohiogenesis 显示文摘BERGERS G BREKKEN R MCMAHO G 2000Nat Cell Biol2000,2,10:1
20Selective inhibition of vascular endothelial growth factor (VEGF) receptor-2(KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice显示文摘Brekken RA Overholser JP Smstny VA 2000Cancer Res2000,60,18:1
返回顶部 每页显示:
共18页 首页 上一页 第1页 下一页 末页 /18 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费